Ad is loading...
HWLIX
Price
$47.94
Change
+$0.51 (+1.08%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
+$0.84 (+1.22%)
Updated
Nov 21 closing price
Ad is loading...

HWLIX vs VVIAX

Header iconHWLIX vs VVIAX Comparison
Open Charts HWLIX vs VVIAXBanner chart's image
Hotchkis & Wiley Large Cap Fdml Value I
Price$47.94
Change+$0.51 (+1.08%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change+$0.84 (+1.22%)
VolumeN/A
CapitalizationN/A
HWLIX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HWLIX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HWLIX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. HWLIX (408M). VVIAX pays higher dividends than HWLIX: VVIAX (2.36) vs HWLIX (1.43). HWLIX was incepted earlier than VVIAX: HWLIX (37 years) vs VVIAX (24 years). HWLIX is a more actively managed with annual turnover of: 26.00 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than HWLIX: VVIAX (3000) vs HWLIX (250000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. HWLIX (16.70). VVIAX return over 5 years is better than : 53.09 vs. HWLIX (44.45).
HWLIXVVIAXHWLIX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years24 years-
Gain YTD18.31219.67293%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets408M184B0%
Annual Yield % from dividends1.432.3661%
Returns for 1 year16.7026.0964%
Returns for 3 years9.5324.7738%
Returns for 5 years44.4553.0984%
Returns for 10 years97.08112.2686%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics